RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5267
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0808100; Gene model (P.falciparum): PF3D7_0317100; Gene product: 6-cysteine protein (B9)
DisruptedGene model (rodent): PBANKA_1006300; Gene model (P.falciparum): PF3D7_0408700; Gene product: perforin-like protein 1 | sporozoite micronemal protein essential for cell traversal (PLP1; PPLP1, SPECT2)
Phenotype Sporozoite; Liver stage;
Last modified: 23 November 2022, 13:26
  *RMgm-5267
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 36403748
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherYuda M, Nishi T
Name Group/DepartmentDepartment of Medical Zoology
Name InstituteMie University School of Medicine
CityMie, Tsu
CountryJapan
Name of the mutant parasite
RMgm numberRMgm-5267
Principal nameB9/SPECT2 DKO parasites
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteFrom analysis of B9(-) parasites (Rmgm-5266):
Normal numbers of motile salivary gland sporozoites are formed. While 30 wild-type sporozoites were sufficient to establish infection in all rats, Even 1 × 10 B9(-) sporozoites were insufficient to establish infection in all rats.
Liver stageFrom analysis of B9(-) parasites (Rmgm-5266):
B9(-) parasites formed abnormal liver stages (LS) and displayed increased cell traversal activity. The number of B9(-) LS parasites formed in HepG2 cells was 6% that of wild-type parasites at 24 and 48 h post-inoculation (hpi) of sporozoites. The average diameter of the B9(-) LS parasites decreased to approximately 80 % that of wild-type LSs at 48 hpi. There was a decreased number of sporozoites entering the hepatocytes by productive invasion and reciprocally, an increased number of sporozoites that continued migration through the hepatocytes. Evidence is presented that B9(-) LS parasites develop in the nucleus of hepatocytes.

From analysis of B9/SPECT2 DKO parasites:
With t he disruption of SPECT2 in B9(-) parasites, the cell traversal activity of sporozoites disappeared. In HepG2 cell culture no LSs of B9/SPECT2 DKO parasites were identified using fluorescence microscopy, demonstrating that all LS parasites inside the nucleus 5 were derived from sporozoites that invaded Hep G2 cells for cell traversal.
Sporozoites in side these cells were still observed in B9 SPECT 2 DKO parasites and the number increased following SPECT2 disruption to a level similar to that of wild type. This result means that sporozoites lacking both cell invasion modes still enter ed HepG2 cells.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of B9 and SPECT2 (and expresses GFP under the constitutive hsp70 promoter).

B9(-)GFP parasites were generated by insertion of a GFP expression cassette into the B9 gene locus  of wild-type parasites by homologous recombination. B9(-)GFP parasites were sorted using flow cytometry. The selected parasites were further separated from wild-type parasites by limiting dilution. Double knockout parasites were prepared from these parasites by additional disruption of SPECT2 using a pyrimethamine resistant gene as a selectable marker. 


Protein (function)
The B9 protein contains a 4-cysteine domain with a structure that is highly similar to the structure of 4-cysteine domains in the known proteins of the 6-Cys family and is identified as a 6-Cys-related protein. B9 is predicted to be glycosylphophatidylinositol (GPI) anchored. 

The spect2/pplp1 gene is a member of a small, conserved family of proteins encoding perforin-like proteins containing membrane-attack complex/perforin domains (MACPF). The P. berghei genome contains 5 PLP proteins. SPECT2/PPLP1 is specifically expressed in salivary gland sporozoites (not in midgut sporozoites) and has a micronemal location (micronemes)

Phenotype
From analysis of B9(-) parasites (RMgm-5266):
Normal numbers of motile salivary gland sporozoites are formed. While 30 wild-type sporozoites were sufficient to establish infection in all rats, even 1 × 10 B9(-) sporozoites were insufficient to establish infection in all rats.B9(-) parasites formed abnormal liver stages (LS) and displayed increased cell traversal activity. The number of B9(-) LS parasites formed in HepG2 cells was 6% that of wild-type parasites at 24 and 48 h post-inoculation (hpi) of sporozoites. The average diameter of the B9(-) LS parasites decreased to approximately 80% that of wild-type LSs at 48 hpi. There was a decreased number of sporozoites entering the hepatocytes by productive invasion and reciprocally, an increased number of sporozoites that continued migration through the hepatocytes. Evidence is presented that B9(-) LS parasites develop in the nucleus of hepatocytes. Evidence is presented that sporozoites lose the capacity to switch invasion modes by disruption of either B9 or P52 (see also mutants RMgm-5267 and RMgm-5268). 
From analysis of B9/SPECT2 DKO parasites
With t he disruption of SPECT2 in B9(-) parasites, the cell traversal activity of sporozoites disappeared. In HepG2 cell culture no LSs of B9/SPECT2 DKO parasites were identified using fluorescence microscopy, demonstrating that all LS parasites inside the nucleus 5 were derived from sporozoites that invaded Hep G2 cells for cell traversal.
Sporozoites in side these cells were still observed in B9 SPECT 2 DKO parasites and the number increased following SPECT2 disruption to a level similar to that of wild type. This result means that sporozoites lacking both cell invasion modes still enter ed HepG2 cells.

Additional information
To demonstrate that B9 is expressed in sporozoites, parasites expressing this gene as a FLAG tagged protein were prepared using a centromere plasmid, followed by immunofluorescent staining of the salivary gland sporozoites. The tag was inserted near the N-terminus of the protein following the predicted signal peptide (because the C-terminus portion is predicted to be cleaved by modification of the glycosylphosphatidylinositol (GPI) anchor. The B9 protein was detected in small particles in the cytoplasm and co localized with P52, suggesting that it is targeted to micronemes as other members of this family that are expressed at this stage.

From the paper analysing B9(-) parasites (RMgm-5266): We also performed cell wounding and membrane repair assays to evaluate the cell traversal activity of B9(-) sporozoites . The number of HepG2 cells damaged by invasion of B9(-) sporozoites was approximately 3 fold higher than that of wild type parasites. These results suggest that the disruption of B9 impaired the switching capacity of sporozoites . More specifically, there was a decreased number of sporozoites entering the hepatocytes by productive invasion and reciprocally, an increased number of sporozoites that continued migration through the hepatocytes . This phenotype of B9(-). is similar to the previously reported phenotypes of P52 disrupted P52(-) and P36 disrupted P36(-) parasites

At 8 hpi wild type sporozoites were observed near the nucleus and inside the PVM, extending towards the nucleus of HepG2 cells. In clear contrast, very few B9(-) sporozoites were observed in the cytoplasm and UIS3 was not detected around them, suggesting that no PVMs were formed around them. Most B9(-) sporozoites were located in the nucleus and were in the process of transform ing in to the LS. UIS 3 was not detected around them. At 24 hpi wild type LS parasites developed into LSs near the nucleus of HepG2 cells At the same time, B9(-) parasites had transformed into LSs inside the nucleus of HepG2 cells and had undergone multiple nuclear divisions. At 48 hpi B9(-) LSs significantly increased in size compared w ith that at 24 hpi, but the progress of their nuclear division varied and their development was obviously delayed compared with that of wild type LSs. No LSs were identified in the cytoplasm at 24 and 48 hpi. An insignificant number of wild type LS parasites were located in side the nucleus of HepG2 cells and, similar to B9 (-) LS parasites, they had no PVMs and exhibited retarded nuclear division. 

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0808100
Gene Model P. falciparum ortholog PF3D7_0317100
Gene product6-cysteine protein
Gene product: Alternative nameB9
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markerunknown
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modificationB9(-)GFP parasites were generated by insertion of a GFP expression cassette into the B9 gene locus of wild-type parasites by homologous recombination.

B9(-)GFP parasites were sorted using flow cytometry. The selected parasites were further separated from wild-type parasites by limiting dilution. Double knockout parasites were prepared from these parasites by additional disruption of SPECT2 using a pyrimethamine-resistant gene as a selectable marker.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1006300
Gene Model P. falciparum ortholog PF3D7_0408700
Gene productperforin-like protein 1 | sporozoite micronemal protein essential for cell traversal
Gene product: Alternative namePLP1; PPLP1, SPECT2
Details of the genetic modification
Inducable system usedDD
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitepbdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationB9(-)GFP parasites were generated by insertion of a GFP expression cassette into the B9 gene locus of wild-type parasites by homologous recombination.

B9(-)GFP parasites were sorted using flow cytometry. The selected parasites were further separated from wild-type parasites by limiting dilution. Double knockout parasites were prepared from these parasites by additional disruption of SPECT2 using a pyrimethamine-resistant gene as a selectable marker.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6